Health Technology Assessment for Universal Health Coverage

Slides:



Advertisements
Similar presentations
India Injection Safety Coalition. If you have an apple and I have an apple and we exchange these apples then you and I will still each have one apple.
Advertisements

SOL-CARE ® Luer Lock Safety Syringe. SOL-MILLENNIUM Medical introduces the new SOL-CARE ® luer lock safety syringe, a product of the SOL-CARE® safety.
Presentation by Cambodian Participants Phuket, Thailand February 2012 Health Impact Assessment Royal Government of Cambodia.
Towards Curative Auto- Disable Syringes Dr Yvan Hutin Department of Blood Safety and Clinical Technology WHO, Geneva.
World Health Organization
“Rational Pharmacology” and Health Economics By Alan Maynard.
Health Technology Assessment and evidence-informed decision making
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
HIGHLIGHTS OF GHANA’S ENVIRONMENTAL FISCAL REFORM POLICY (WIP) Presented by: Ebenezer Nortey (Ministry of Finance) at UNEP Regional Workshop on Inclusive.
Intelligence Unit 6 - Mandates for Action Policy exerts a powerful influence on public health nutrition (PHN) practice because it affects:  service delivery.
R2HC Third Call for Proposals Launch
Moving towards the goal of Universal Health Coverage (UHC) in Bangladesh Md. Ashadul Islam Director General Health Economics Unit Ministry of Health and.
NDA Conference Resource Allocation in the Irish Health Services Charles Normand Edward Kennedy Professor of Health Policy & Management University of Dublin.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
NICE Decision Making Dr Katherine Payne North West Genetics Knowledge Park The University of Manchester
Handicap-International Challenges of the Sustainability of physical rehabilitation sector Nepal, January 2013.
Cost-Effectiveness Thresholds Professor of Health Economics
Injection Safety IPV Global Workshop March 25, 2014.
Co-ordinated by: World Health Organization European Office for Integrated Health Care Services, Barcelona Technically supported by: WHO Collaborating Centre.
05_XXX_MM1 Implementing Safe Abortion: technical and policy guidance for health systems Ronnie Johnson, PhD UNDP/UNFPA/WHO/World Bank Special Programme.
GAVI/Vaccine Fund Support to Improve Injection Safety On behalf of the Injection Safety sub-group.
Workshop The science and methodologies behind HTA, diversity and commonality across the EU Achieving more patient centred HTA in different countries.
HERU is supported by the Chief Scientist Office of the Scottish Executive Health Department. The author accepts full responsibility for this talk. Economic.
HTA cooperation in the EU EPF workshop Jérôme Boehm 18 May 2010.
Africa Health Workforce Platform & Observatory Presentation to the 1st conference of the Asia-Pacific Action Alliance on HRH (AAAH): October 2006.
USING ECONOMIC EVIDENCE AND STAKEHOLDER'S PARTICIPATION IN DECISION MAKING ON BENEFIT PACKAGE OF UNIVERSAL HEALTH COVERAGE SCHEME IN THAILAND RESULTS:
Themes Emerging from Country and Related Presentations Notes from session 1545 – 1730 Thursday 17 February 2011 Albert Weale.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
Prevention of Blood-Borne Pathogen Transmission in Egypt Ministry of Health and Population Arab Republic of Egypt.
Universal Health Coverage:
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Conferenceboard.ca Aligning, Foreseeing, and Optimizing HTA in Canada 2016 CADTH Symposium April 12, 2016 Dr. Gabriela Prada Director, Health Innovation.
OUR FOCUS FOR 2011 TO 2012 The CfWI produces quality intelligence to inform better workforce planning, that improves people’s lives.
NETWORK CONFIGURATION (IHSDNs Attribute # 1 and 2) July , 2015 Belize REYNALDO HOLDER Health Services and Access Unit Department of Health Systems.
1 Mongolia - Vision Long term vision All residents of the capital city (Ulaanbaatar) of Mongolia will have access to improved water supply and sanitation.
Dr Charmaine Gauci Superintendent of Public Health/Director General PH
Sustainable Livelihoods: A Gender Sensitive Approach
Health Technology Assessment
Roadmap for Health in All Policies in Sudan
Kalipso Chalkidou, MD, PhD
Presentation Developed for the Academy of Managed Care Pharmacy
Measuring Progress Toward UHC
Sustainable Livelihoods: A Gender Sensitive Approach
Research Translation: Lessons from Dissemination and Implementation Research for Interventions Promoting Walking and Walkability August 18, am Pacific,
Social Protection Interagency Board Meeting New York, 2-3 July 2012
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
The NICE Citizens Council and the role of social value judgements
Compensation Fund Priorities:
Government Spending to Achieve Sustainable Development Policy Goals
Lecture 9: PHC As a Strategy For HP Dr J. Sitali
National health policy review
Wednesday 16 May 2018 Zagreb, Croatia
How to Measure Impact of Health Leadership Development
Why do/should we do economic evaluation?
Advisory group meeting 2015
Integrating HTA into Public Health Policies
Health Technology Assessment for Universal Health Coverage
Sudan’s Health Sector Reform; addressing the SDGs
Primary Health Care Improvement Global Stakeholder Meting, Geneva
Advancing Partnerships for Universal Health Coverage
Worcestershire Joint Services Review
Health Technology Assessment in India
Erasmus+ KA2 project: Enhancement of study programs in Public Health Law, Health Management, Health Economics and Health Informatics in Montenegro European.
Kenya’s Journey towards Optimal Medical Devices Management
National Health Policy and Strategic Shifts
Health Impact Assessment in NSW
Roadmap for Health in All Policies in Sudan
Share your thoughts on this presentation with #IAS2019
Impact of quality on day-to-day efforts of PHC
Presentation transcript:

Health Technology Assessment for Universal Health Coverage Dr Shankar Prinja Additional Professor of Health Economics School of Public Health Post Graduate Institute of Medical Education and Research, Chandigarh UHC Day, 12 Dec 2017, Delhi

Outline HTA: Concept Institutionalization of HTA in India Illustration: HTA on Safety Engineered Syringes Way Forward

Health Technology Assessment (HTA) Multidisciplinary process that summarizes information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient/population focused and cost-effective European network for Health Technology Assessment. Common Questions. What is Health Technology Assessment (HTA). Accessed Aug. 1, 2013 at: http://www.eunethta.eu/about-us/faq#t287n73

What does word Health Technology mean? Medical devices & Implants Drugs Health programs & platforms of care Diagnostics Health technology refers to any method that is used to promote health prevent, diagnose and treat diseases or improve rehabilitation and long-term care.

Scope of HTA Investment decisions Dis-investment decisions Whether to Invest in Newer Technologies Whether to Scale up Newer Technologies Discontinue the existing health technology/intervention Re-allocate/ reduce allocation to health technology/ intervention Courtesy: Dr Yot

How Does HTA guide UHC Strategic Purchasing? Better than some current technologies Health benefit per $1,000 Worse than all current technologies Threshold Health care expenditures Interventions ranked highest to lowest Other candidates (eg new technologies) Budget

How Does HTA guide UHC Strategic Purchasing? Health benefit per $1,000 New Threshold Threshold Health care expenditures Budget

How Does HTA guide UHC Strategic Purchasing? Health benefit per $1,000 Net health gain from using HITA Health care expenditures Budget

Status of HTA in India Medical Technology Assessment Board established in the Department of Health Research, Government of India Recommendatory body to the Ministry of Health and Family Welfare Evaluate new and existing health care interventions Guide India’s priority setting under UHC reforms Prinja S et al (2017). Health Technology Assessment for Policy Making in India: Current Scenario and Way Forward. Pharmacoeconomics Open. Published online 13 June 2017

MTAB Activities: Early Phase Setting the principles and scope of HTA Maximizing health Equity Reduce OOP expenditures Identifying the criteria for decision making Development of process guidelines Hub and spoke model: Secretariat & technical partner MTAB Resource Centre: PGI Chandigarh, others to be set up Technical Advisory Committee & Board

KEY PHASES OF THE HTA PROCESS Topic Selection Technical partner identification Proposal development Research and analysis Appraisal of the evidence Dissemination

Prinja S et al (2015). Applied Health Econ Health Policy.

Capacity Building for HTA Series of DHR funded training workshops planned 1st workshop held at Kerala Focus of building skills for HTA Online Courses followed by face to face training and sustained mentorship http://healtheconomics.pgisph.in/

Methodological Work at MTAB Developing a reference case for HTA in India Costing Database Developing Indian tariff values for EQ5D health states

Safety Engineered Syringes Auto-disable (AD) Syringes: Safety plunger breaks off or metal clip that locks the plunger with the full depression of plunger after a single use It contains fixed dosing mark Used in immunization sector Reuse prevention Syringes: Safety plunger breaks off or metal clip that locks the plunger or the needle retracts into the barrel after a single use It contains variable dosing marks Used in therapeutic sector

Safety Engineered Syringes Sharp Injury Prevention (SIP): A plastic needle shield slides over the needle after the injection is given which ensures that the needle cannot accidentally “stick” anyone else (i.e. healthcare workers (HCWs), waste handlers and the community) Syringe with both SIP + RUP feature SIP syringes include syringes with a feature that draws the needle up into the syringe barrel (retraction of needle) The retraction occurs automatically or manually

Cost-effectiveness of SES (RUP) ICER (INR, Societal Perspective) Life Year (Undiscounted) 911 Life Year (Discounted) 8,118 QALY (Undiscounted) 879 QALY (Discounted) 7,608

Cost-Effectiveness Acceptability Curve

Threshold Analysis RUP Syringe

Threshold Analysis (SIP+RUP)

Threshold Analysis (SIP) Cost-effective Dominant

Challenges Political economy Health financing scenario UHC needs more than just HTA Political commitment and allocations for HTA

Thanks Email: shankarprinja@gmail.com